WallStreetZenWallStreetZen

NASDAQ: RNAC
Cartesian Therapeutics Inc Stock Ownership - Who owns Cartesian Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cartesian Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carsten BrunnPresident and CEO2026-01-0623,766$6.82
$162.08kSell
Blaine DavisChief Financial Officer2026-01-0610,591$6.82
$72.23kSell
Milos MiljkovicChief Medical Officer2026-01-063,573$6.82
$24.37kSell
Emily EnglishChief Operations Officer2025-12-307,500$3.30
$24.75kBuy
Timothy C. BarabeDirector2025-12-0430,000$6.86
$205.80kBuy
Emily EnglishChief Operations Officer2025-11-287,500$3.30
$24.75kBuy

1 of 1

RNAC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNAC insiders and whales buy or sell their stock.

RNAC Shareholders

What type of owners hold Cartesian Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Timothy A. Springer36.95%11,179,069$70.88MInsider
Murat Kalayoglu19.24%5,820,260$36.90MInsider
Elizabeth Hoge19.24%5,820,260$36.90MInsider
Amir Nashat8.85%2,676,234$16.97MInsider
Polaris Venture Management Co V LLC6.20%1,876,020$11.89MInsider
Carl L. Gordon6.03%1,825,415$11.57MInsider
Orbimed Advisors LLC6.03%1,825,415$11.57MInsider
Flagship Ventures Fund 2007 LP5.46%1,651,862$10.47MInsider
Rusnano4.88%1,476,177$9.36MInsider
Tas Partners LLC4.09%1,237,028$7.84MInsider

1 of 3

RNAC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNAC0.02%99.98%Net Buying
DTIL0.06%99.94%Net SellingNet Buying
NAGE0.02%99.98%Net Buying
ALXO0.08%10.66%Net BuyingNet Selling
PALI0.10%9.39%Net SellingNet Selling
View Top Biotech Stocks

Cartesian Therapeutics Stock Ownership FAQ

Who owns Cartesian Therapeutics?

Cartesian Therapeutics (NASDAQ: RNAC) is owned by 0.03% institutional shareholders, 140.36% Cartesian Therapeutics insiders, and 0.00% retail investors. Timothy A. Springer is the largest individual Cartesian Therapeutics shareholder, owning 11.18M shares representing 36.95% of the company. Timothy A. Springer's Cartesian Therapeutics shares are currently valued at $70.88M.

If you're new to stock investing, here's how to buy Cartesian Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.